Сиалис

Quick links to important sections

Сиалис

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Сиалис

Quick Facts: Tadalafil

Property Description
Active ingredient Tadalafil
Form Film-coated tablets (Oral)
Pharmacological class Selective Phosphodiesterase type 5 (PDE5) Inhibitor
General purpose Enhances blood flow in specific tissues
Origin Synthetic compound

What is Сиалис: Definition and Origin

Сиалис (Cialis) is a medication that requires a prescription, containing the single synthetic compound, Tadalafil. It is chemically classified as a highly selective Phosphodiesterase type 5 (PDE5) inhibitor. This classification relates to its systemic role in vascular management. Tadalafil is differentiated from other agents in its class by a long duration of effect, which supports flexibility for the user compared to compounds with shorter metabolic half-lives. This characteristic contributes to the drug's distinct therapeutic profile.

Form, Composition, and General Function

Сиалис is presented as an oral film-coated tablet, suitable for oral administration. The tablet composition is a single-component product wherein Tadalafil is combined with inactive excipients necessary for stability and proper dissolution. The general function of the drug is to enhance the body's natural response to stimulation by blocking the PDE5 enzyme, an action that facilitates smooth muscle relaxation. This mechanism results in enhanced blood flow to targeted areas, which is the foundational therapeutic benefit. The overall action supports vascular health.

What side effects are possible with Сиалис?

Possible Side Effects and Safety Information

The safety profile of Tadalafil (Сиалис) is formally documented in government regulatory sources, which categorize potential adverse reactions by frequency and affected body system. Understanding these classifications is key to grasping the official risk profile of the medication.


Frequency-Classified Adverse Reactions

The most frequent adverse reactions listed in official documents include Headache and Dyspepsia (indigestion/heartburn), which are often classified as Very Common or Common. Other Common effects involve the musculoskeletal and vascular systems, such as Back pain, Myalgia (muscle aches), Flushing, and Nasal congestion.

Effects classified as Uncommon include hypersensitivity reactions, rash, and visual defects. Rare reactions documented in post-marketing experience involve events such as Priapism (prolonged erection), Non-arteritic Anterior Ischaemic Optic Neuropathy (NAION), and sudden decrease or loss of hearing.


Serious Adverse Reactions and Restrictions

Regulatory documents highlight several Serious Adverse Reactions, including the aforementioned Priapism, which necessitates immediate attention to prevent tissue damage. Serious cardiovascular events, such as myocardial infarction and stroke, have been reported in temporal association with use.

Specific Safety Restrictions are defined in official labeling. Tadalafil is strictly contraindicated for use in individuals concurrently taking any form of Organic Nitrates or Guanylate Cyclase (GC) Stimulators due to the risk of severe hypotension. Furthermore, caution is advised and use may be non-recommended in patients with severe renal or hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation states that the manifestations observed following Tadalafil overdose are generally similar to the adverse events seen at therapeutic doses, which may include headache, dyspepsia, back pain, and flushing.


Required Emergency Actions

The regulatory guidance mandates seeking immediate medical assistance for several documented severe outcomes. Urgent help is required for priapism, defined as an erection lasting four hours or longer, due to the documented risk of penile tissue damage and permanent loss of potency.

Furthermore, individuals must stop taking Tadalafil and consult a physician immediately upon experiencing a sudden decrease or loss of vision or a sudden decrease or loss of hearing. Serious outcomes documented in post-marketing surveillance include myocardial infarction and stroke, particularly in individuals with pre-existing risk factors.


Management and Considerations

In the event of an overdose, management involves adopting standard supportive measures, as no specific antidote is known. The official label specifies that Tadalafil is not significantly cleared by hemodialysis, meaning dialysis is not effective in reducing systemic exposure. Increased drug exposure is documented in patients with severe renal or hepatic impairment.

Therapeutic Uses of Сиалис

Quick Facts: Approved Therapeutic Domains

  • Tadalafil supports management of Erectile Dysfunction (ED), assisting with achieving and maintaining an erection sufficient for sexual activity.
  • It provides therapeutic support for the signs and symptoms of Benign Prostatic Hyperplasia (BPH), which involves an enlarged prostate.
  • It is also indicated for the management of both conditions concurrently.

What Tadalafil (Cialis) Treats: Main Uses and Benefits

Tadalafil (marketed as Cialis) is a prescription medication approved for the management of specific conditions in adults. The primary therapeutic use of tadalafil is to address Erectile Dysfunction (ED), a condition where individuals may experience difficulty developing or sustaining an erection. For this indication, the medication supports erectile function when sexual stimulation is present, allowing for satisfactory sexual activity.

Another authorized use is the supportive care for the signs and symptoms associated with Benign Prostatic Hyperplasia (BPH), commonly referred to as an enlarged prostate. Treatment with tadalafil can help relieve lower urinary tract symptoms linked to BPH, such as issues with urinary flow or urgency. The medication is also indicated for patients diagnosed with both erectile dysfunction and the signs of benign prostatic hyperplasia. These indications apply to the clinical management of these specific health conditions.

Eligibility and Restrictions for Use

Tadalafil is officially indicated for use by Adult Men (18 years and older) for its approved applications. Eligibility is strictly defined by regulatory bodies (e.g., FDA, EMA) based on contraindications and patient health status.

Use Status Prohibited Population / Condition
CONTRAINDICATED Patients using any form of organic nitrate or Guanylate Cyclase (GC) Stimulators (e.g., riociguat).
CONTRAINDICATED Patients with a history of NAION (Non-Arteritic Anterior Ischaemic Optic Neuropathy) resulting in vision loss in one eye.
CONTRAINDICATED Men with recent cardiovascular events (e.g., stroke within 6 months, MI within 90 days), unstable angina, or uncontrolled blood pressure.

Use is not recommended in patients with severe hepatic impairment (Child-Pugh Class C) or severe renal impairment (CrCl le 30 mL/min) due to limitations in safety data or drug clearance. The medication is not indicated for the pediatric population (under 18 years). In pregnancy and during breastfeeding, use is preferable to avoid or requires caution, as officially documented. Use also requires caution in patients with conditions predisposing to priapism (e.g., Sickle-cell anemia).

What should I know about interactions with other medicines?

Tadalafil (Cialis) has the potential to interact with several types of medications and substances, primarily due to its effect on blood pressure and its metabolic pathway in the liver. Patients should always discuss all medications, supplements, and lifestyle habits with a healthcare provider before starting treatment.

Major Contraindicated Interactions

The most critical interaction involves Nitrates (e.g., nitroglycerin, isosorbide dinitrate, isosorbide mononitrate) and Guanylate Cyclase (sGC) Stimulators (e.g., riociguat). Combining Cialis with these agents is strictly contraindicated, as it can cause a sudden, severe, and dangerous drop in blood pressure (hypotension), which can be life-threatening. If nitrates are medically necessary for chest pain after Cialis use, at least 48 hours should pass since the last dose, and they must be administered under close medical supervision.

Interactions Requiring Caution and Dose Adjustment

  • Alpha-Blockers (used for high blood pressure or Benign Prostatic Hyperplasia, BPH): Co-administration can cause an additive blood pressure-lowering effect, increasing the risk of dizziness and fainting. Cialis should only be initiated after a patient is stable on their alpha-blocker therapy, typically starting with the lowest Cialis dose.
  • Potent CYP3A4 Inhibitors (e.g., ritonavir, ketoconazole, some antibiotics and antifungals): These drugs interfere with the liver enzyme that breaks down tadalafil, significantly increasing its concentration in the blood. This raises the risk of Cialis side effects, including prolonged erection (priapism) and low blood pressure. Dose adjustment of Cialis is generally required.
  • Antihypertensives and Excessive Alcohol: Tadalafil can potentiate the effects of other blood pressure-lowering drugs and heavy alcohol consumption (typically five or more units), potentially leading to hypotension.

Mechanism of Action

Selective Targeting of the PDE5 Enzyme

Tadalafil acts as a selective and reversible inhibitor of the Phosphodiesterase type 5 ( PDE5) enzyme, which is responsible for breaking down the cellular messenger cGMP. By binding to PDE5, the drug prevents the rapid deactivation of this key molecule, thereby engaging mechanisms that regulate vascular physiological processes.


Sustaining the Natural NO- cGMP Signaling

The primary effect is the sustained duration and increased level of the natural Nitric Oxide ( NO)-cGMP pathway. This mechanism ensures that the cGMP signal—produced following specific biological stimulation—is maintained at an elevated concentration. This action modifies early molecular steps that shape systemic physiological outcomes, leading directly to the next stage of the cascade.


Facilitation of Vascular Smooth Muscle Relaxation

The sustained high level of cGMP leads to the activation of intracellular protein kinases, which initiate a cascade that decreases the concentration of intracellular calcium ( Ca^2+). This decrease directly causes the relaxation (vasodilation) of the arterial smooth muscle. The physiological consequence is an increased perfusion of blood to the local tissue beds, contributing to the modulation of activity within targeted pathways.

Dosage and Administration Information

How Tadalafil (Сиалис) is Used

The administration of Tadalafil (Сиалис) is based on two distinct patterns: intermittent (as-needed) use and continuous (once-daily) maintenance therapy. The medication is delivered via the oral route as a film-coated tablet. It can be taken with or without food, as absorption is not affected by food intake.


Dosing Regimens

Tadalafil is available in strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg. The dosage is determined by the treatment pattern and specific condition.

Condition / Use Pattern Starting Dose Maximum Frequency / Dose
Erectile Dysfunction (ED) (As-Needed) 10 mg prior to activity No more than once per day; maximum single dose of 20 mg
Erectile Dysfunction (ED) (Once-Daily) 2.5 mg once daily Maximum daily dose of 5 mg
Benign Prostatic Hyperplasia (BPH) or Concurrent Use N/A (Maintenance) 5 mg once daily

Procedural Constraints and Adjustments

When using the intermittent pattern, the medication is administered in anticipation of sexual activity. For the continuous once-daily regimen, the tablet should be taken at approximately the same time each day. A forgotten dose in the once-daily regimen should be taken at the usual time, and the next dose should not be doubled to make up for the missed one.

Adjustments are applicable for specific populations: the 5 mg daily dose is generally not recommended for patients with moderate or severe hepatic impairment, and specific dose limits apply to those with severe renal impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Сиалис (Tadalafil)

Evidence Overview for Erectile Dysfunction (ED)

Clinical evaluation for Tadalafil in the context of Erectile Dysfunction (ED) was studied primarily through randomized controlled trials (RCTs). These short-term RCTs, along with compiled data from meta-analyses, contribute to the broader evidence landscape. Research examined adult men across a range of symptom intensity or variability related to ED.

The studies explored specific patient-reported outcomes related to erectile function and the ability to engage in sexual activity. Findings describe patterns observed in the studies where patient-reported function scores were evaluated over defined time intervals. Research has also explored cohorts of men where ED occurred alongside other conditions, such as diabetes mellitus and controlled hypertension.

Evidence Overview for Benign Prostatic Hyperplasia (BPH) Symptoms

Tadalafil was evaluated in research settings involving conditions characterized by fluctuating symptoms, specifically the Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH). The evidence base here also relies heavily on short-term RCTs, often followed by extension studies lasting up to one year.

Research explored patient-reported outcomes describing perceived discomfort, primarily using the International Prostate Symptom Score (IPSS) and a related quality-of-life index. Studies monitored both men with LUTS alone and men with coexisting ED and BPH symptoms. A key limitation noted is that while studies contribute to understanding symptom patterns, the evidence did not report consistent, significant changes in more objective measures, such as maximum urine flow rate.

Long-Term Studies and Durability of Follow-up

The core evidence primarily derives from short-term trials. To gain insight into longer periods, researchers conducted open-label extension studies, which monitored outcomes over defined time intervals. The research describes how symptoms evolved in the observed populations over these longer periods. However, the evidence remains limited concerning how the medicine might affect patients over multi-decade use.

Gaps and Uncertainty in the Research Record

For the BPH indication, comparative evidence is lacking that would demonstrate a corresponding change in objective urinary flow measures alongside subjective symptom changes. Furthermore, limited information exists for long-term outcomes, particularly concerning whether the research record includes data on the use of the medicine and a corresponding reduction in the need for BPH-related surgical interventions. The clinical relevance of the drug's observed activity on the PDE11 enzyme in human physiology has not been fully established.

Key Studies & References

  1. Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a meta-analysis
  2. Real-World Safety and Effectiveness of Tadalafil in Patients with Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia: An 18-Month Prospective Observational Study
  3. Phosphodiesterase Type 5 (PDE5) Inhibitors - StatPearls (NIH/NCBI)

Frequently Asked Questions (FAQ)

Common questions about Сиалис (FAQ)


Q: What is the difference between Сиалис and other similar medicines for erectile dysfunction?

Official information notes that when taken as needed, tadalafil was shown to improve erectile function for up to 36 hours following dosing. This notably long duration of effect is a key characteristic mentioned in regulatory descriptions compared to other PDE5 inhibitors.


Q: Is it true that Сиалис is effective for up to 36 hours?

Clinical trial data presented in official documents indicates that the medicine was shown to improve erectile function compared to placebo for up to 36 hours after a single dose. This sustained window of activity is one of the distinct features described in the drug's regulatory profile.


Q: Does Сиалис only work if a person is sexually stimulated?

According to the official product information, the medicine is not expected to be effective in the absence of sexual stimulation. Its mechanism depends on the body’s natural response to stimulation to trigger the chemical cascade that results in better blood flow.


Q: Can individuals with heart conditions safely use Сиалис?

Regulatory documents state that use is strictly contraindicated (forbidden) for men with certain recent or unstable heart conditions, such as a heart attack within the last 90 days, or unstable angina. It is also prohibited for patients with heart disease for whom sexual activity is considered inadvisable. A thorough evaluation is required for individuals with any heart condition before considering this medication.


Q: Does Сиалис lower blood pressure, and is this a concern with other medications?

Tadalafil has properties that cause a mild and temporary decrease in blood pressure due to widening of the blood vessels (vasodilation). This effect is a safety concern because it may enhance the blood pressure-lowering effects of other medicines, such as antihypertensives, which has the potential to contribute to low blood pressure (hypotension).


Q: Does eating grapefruit or drinking grapefruit juice affect how Сиалис works?

While grapefruit is not always named, the medicine is processed primarily by the CYP3A4 enzyme in the liver. Products that inhibit or block this enzyme, which includes grapefruit and grapefruit juice, can potentially increase the concentration of tadalafil in the body. This may increase drug exposure, which could raise the risk of side effects.


Q: Is there a daily-use version of Сиалис, and what is its purpose?

Yes, Tadalafil is approved for a once-daily regimen at lower doses. This daily regimen is approved for the treatment of erectile dysfunction, symptoms of benign prostatic hyperplasia (BPH), or for both conditions when they occur together. This approach is intended to maintain a consistent level of the drug in the body.


Q: Can older men, such as those over 65, use Сиалис safely?

Official guidelines state that no dose adjustment is automatically needed for men 65 years and older based on age alone. However, due to the possibility of greater sensitivity to medications in some older individuals, special consideration is generally noted in official guidelines.


Q: Are there any special considerations for people with liver or kidney problems who want to use Сиалис?

Yes, special dose adjustments and restrictions are necessary for patients with impaired kidney function (renal impairment). Once-daily use is generally not recommended for people with severe kidney or severe liver problems due to limited safety data or concerns about how the body clears the drug.


Q: Does using Сиалис for a long time lead to any long-term side effects?

Clinical trials included extension studies to monitor outcomes over defined longer periods. The most commonly reported side effects, such as headache, back pain, and muscle aches, were generally described as temporary, mild, or moderate in nature. The research record on multi-decade use remains limited.


Q: How quickly does Сиалис typically start to work after it is taken?

When taken as needed, the medicine is generally taken at least 30 minutes prior to anticipated sexual activity. Factual information from clinical studies indicates that the median time for the drug to reach its maximum concentration in the bloodstream is approximately two hours.


Q: Is there any difference in how generic tadalafil works compared to brand-name Сиалис?

Regulatory agencies require that approved generic versions of a drug be bioequivalent to the brand-name product. This means they must contain the identical active ingredient (tadalafil) and be absorbed at the same rate and extent, with the goal of providing the same therapeutic effect.


Q: Can Сиалис be taken on an empty stomach or with food?

Official product information states that the medicine may be taken with or without food. The regulatory instructions specify that proper absorption is not dependent on mealtimes.


Q: How does Сиалис specifically help with symptoms of an enlarged prostate?

The drug's action as a PDE5 inhibitor is thought to lead to the relaxation of smooth muscle tissue in the prostate and bladder. This effect may increase blood flow to these areas and relax the muscle of the lower urinary tract, potentially improving symptoms associated with benign prostatic hyperplasia (BPH).


Q: Does taking Сиалис daily lead to better results than taking it 'as needed'?

The choice between daily or as-needed use depends on patient lifestyle. The once-daily regimen is designed to maintain a consistent level of the drug, allowing for readiness at any time. The as-needed dose provides a concentrated effect that lasts up to 36 hours. Official documents do not state a definitive comparative outcome regarding superior efficacy for one regimen over the other.


Q: Can Сиалис be used to treat problems related to an enlarged prostate (BPH)?

Yes, Tadalafil is officially approved and indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men. This is one of the defined therapeutic uses recognized by major health agencies.


Q: Is it possible for Сиалис to cause changes in vision or hearing?

Post-marketing reports have documented sudden decrease or loss of hearing in temporal association with the use of the drug. Furthermore, rare cases of a condition causing sudden vision loss (Non-arteritic Anterior Ischaemic Optic Neuropathy or NAION) have also been reported.


Q: Is it true that some users report intense muscle pain in their legs or back after taking Сиалис?

Muscle pain (myalgia) and back pain are commonly reported side effects of the drug in clinical studies. Regulatory documents describe these effects as typically dose-dependent, temporary, and generally mild or moderate in severity.


Q: What happens to the active ingredient in Сиалис (tadalafil) after 36 hours?

Tadalafil has a mean terminal half-life of approximately 17.5 hours, meaning it takes that long for half the drug to leave the system. After 36 hours, the drug is in the process of being metabolized by liver enzymes and then excreted primarily through the feces and, to a lesser extent, through the urine.


Q: Why is Сиалис available only by prescription and not over-the-counter?

The drug is currently classified as prescription-only due to the need for professional medical supervision. This is necessary to ensure a proper diagnosis, assess potential underlying cardiovascular risks, and thoroughly screen for severe contraindications, such as the use of nitrates.


Q: Does Сиалис help with sexual desire (libido)?

The medicine is approved and indicated only for the treatment of physical conditions like erectile dysfunction and BPH. Its mechanism is focused on vascular health and blood flow, and its approval is based on improving erectile function, not on affecting sexual desire or libido.


Q: Does Сиалис have any known effects on fertility or sperm count?

No adverse effects on sperm concentration, sperm count, sperm motility, or reproductive hormones were reported in the context of the limited trials. The clinical studies assessed parameters over a 6-month period.


Q: Can Сиалис be used by women for any approved condition?

No, Tadalafil (Cialis) is not indicated for use by women. The official product labeling specifies its indications are only for adult men for the treatment of erectile dysfunction and benign prostatic hyperplasia.


Q: Does Сиалис affect the heart rate or cause palpitations?

While the drug's mechanism causes a mild decrease in blood pressure, post-marketing surveillance reports have documented events such as palpitations (irregular heartbeats) and tachycardia (increased heart rate) in temporal association with its use. These effects are documented as uncommon or rare events in regulatory safety data.


Q: What are the symptoms of a serious allergic reaction to Сиалис?

Regulatory documents indicate that serious adverse skin reactions, including life-threatening conditions like Stevens-Johnson syndrome, have been reported rarely. Signs of general hypersensitivity, such as rash and hives (urticaria), have been reported as uncommon side effects.


Q: Why is it important for a doctor to know the patient's full medical history before prescribing Сиалис?

Official regulatory guidelines emphasize that a complete medical history and physical examination are necessary before prescribing. This process is required to determine the underlying cause of the condition and to screen for severe contraindications, such as the use of nitrates, to minimize life-threatening safety risks.


Q: Can Сиалис be used if a person has a physical condition like Peyronie's disease?

Regulatory warnings indicate that Tadalafil should be used with caution in patients with anatomical deformation of the penis. This includes conditions such as Peyronie’s disease, angulation, or cavernosal fibrosis, as well as in patients predisposed to a prolonged erection (priapism).


Q: Are there different forms or shapes of the tablet between brand-name and generic versions?

Generic drugs must match the brand-name product in active ingredient and effect, but they may use different inactive ingredients. These differences can result in variations in the tablet’s appearance, including its size, shape, or color, between brand-name Cialis and generic tadalafil.


Q: Is there a risk of counterfeit Сиалис when buying online?

Regulatory agencies advise that consumers use only government-authorized or licensed pharmacies to ensure the product received is the approved and verified drug. These agencies often warn consumers about the risk of counterfeit medications when purchasing through unverified online sources.


Q: Does the effectiveness of Сиалис change based on the severity of erectile dysfunction?

Clinical trials for the drug included men with mild, moderate, and severe erectile dysfunction. Official clinical summaries describe improved function observed across all these groups, with the effectiveness ultimately linked to the patient's individual physical response and the specific dose prescribed.

How should Сиалис be stored and disposed of?

Storage Requirements and Protection

CIALIS tablets must be stored according to officially defined conditions to ensure product integrity. Regulatory documents specify that the tablets should be stored at 25 C (77 F), with a permissible range between 15 C and 30 C (59 F and 86 F). The product must be kept in the original package in order to protect from moisture and light. It is required that the medicine be kept out of the sight and reach of children.

Disposal Instructions

Any unused or expired CIALIS must be disposed of in accordance with local requirements. Regulatory authorities prioritize disposal via a drug take-back program. Tadalafil is not on the list of medicines recommended for flushing down the toilet. Disposal should generally avoid wastewater or ordinary household waste, unless the medicine is first mixed with an unappealing substance, sealed, and then placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Сиалис found in:

A-Z Index: